1. Home
  2. KSCP vs SPRO Comparison

KSCP vs SPRO Comparison

Compare KSCP & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KSCP
  • SPRO
  • Stock Information
  • Founded
  • KSCP 2013
  • SPRO 2013
  • Country
  • KSCP United States
  • SPRO United States
  • Employees
  • KSCP N/A
  • SPRO N/A
  • Industry
  • KSCP Telecommunications Equipment
  • SPRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • KSCP Telecommunications
  • SPRO Health Care
  • Exchange
  • KSCP Nasdaq
  • SPRO Nasdaq
  • Market Cap
  • KSCP 45.7M
  • SPRO 45.7M
  • IPO Year
  • KSCP 2022
  • SPRO 2017
  • Fundamental
  • Price
  • KSCP $8.02
  • SPRO $0.83
  • Analyst Decision
  • KSCP Strong Buy
  • SPRO Buy
  • Analyst Count
  • KSCP 1
  • SPRO 4
  • Target Price
  • KSCP $16.00
  • SPRO $5.00
  • AVG Volume (30 Days)
  • KSCP 285.4K
  • SPRO 217.5K
  • Earning Date
  • KSCP 03-31-2025
  • SPRO 03-12-2025
  • Dividend Yield
  • KSCP N/A
  • SPRO N/A
  • EPS Growth
  • KSCP N/A
  • SPRO N/A
  • EPS
  • KSCP N/A
  • SPRO 0.06
  • Revenue
  • KSCP $11,005,000.00
  • SPRO $106,455,000.00
  • Revenue This Year
  • KSCP N/A
  • SPRO N/A
  • Revenue Next Year
  • KSCP $21.00
  • SPRO N/A
  • P/E Ratio
  • KSCP N/A
  • SPRO $12.71
  • Revenue Growth
  • KSCP N/A
  • SPRO 37.01
  • 52 Week Low
  • KSCP $4.89
  • SPRO $0.74
  • 52 Week High
  • KSCP $31.50
  • SPRO $1.89
  • Technical
  • Relative Strength Index (RSI)
  • KSCP 31.72
  • SPRO 44.07
  • Support Level
  • KSCP $9.46
  • SPRO $0.82
  • Resistance Level
  • KSCP $9.20
  • SPRO $0.85
  • Average True Range (ATR)
  • KSCP 0.74
  • SPRO 0.05
  • MACD
  • KSCP -0.11
  • SPRO 0.01
  • Stochastic Oscillator
  • KSCP 2.75
  • SPRO 43.33

About KSCP Knightscope Inc.

Knightscope Inc is an advanced security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: